0001140361-13-022541.txt : 20130523 0001140361-13-022541.hdr.sgml : 20130523 20130523171404 ACCESSION NUMBER: 0001140361-13-022541 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20130522 FILED AS OF DATE: 20130523 DATE AS OF CHANGE: 20130523 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MULVENA DANIEL M CENTRAL INDEX KEY: 0001218705 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-49798 FILM NUMBER: 13869273 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: THORATEC CORP CENTRAL INDEX KEY: 0000350907 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 942340464 STATE OF INCORPORATION: CA FISCAL YEAR END: 0102 BUSINESS ADDRESS: STREET 1: 6035 STONERIDGE DR CITY: PLEASANTON STATE: CA ZIP: 94588 BUSINESS PHONE: 9258478600 MAIL ADDRESS: STREET 1: 6035 STONERIDGE DR CITY: PLEASANTON STATE: CA ZIP: 94588 FORMER COMPANY: FORMER CONFORMED NAME: THORATEC CARDIOSYSTEMS INC DATE OF NAME CHANGE: 20010220 FORMER COMPANY: FORMER CONFORMED NAME: THORATEC LABORATORIES CORP DATE OF NAME CHANGE: 19920703 4 1 doc1.xml FORM 4 X0306 4 2013-05-22 0 0000350907 THORATEC CORP THOR 0001218705 MULVENA DANIEL M 6035 STONERIDGE DRIVE PLEASANTON CA 94588 1 0 0 0 Common Stock 2013-05-22 4 A 0 5651 0. A 30072 D Represents restricted stock units. Each restricted stock unit represents a right to receive one share of Thoratec Corporation common stock upon vesting. The restricted stock units fully vest on the one year anniversary of the grant. Annual stock grant according to the Company's Amended and Restated 2006 Incentive Stock Plan. Restricted stock units were granted pursuant to the Company's Amended and Restated 2006 Incentive Stock Plan with no payment received for the restricted stock units. /s/ David A. Lehman, Attorney-In-Fact 2013-05-23 EX-24 2 poa1.htm POWER OF ATTORNEY Unassociated Document
POWER OF ATTORNEY FOR SECTION 16 REPORTING

The undersigned hereby appoints David A. Lehman, in his capacity as Senior Vice President and General Counsel of Thoratec Corporation (the "Company"), Taylor C. Harris, in his capacity as Vice President and Chief Financial Officer of the Company, and any of them with full power of substitution or their respective successors in any such offices, as the attorney-in-fact of the undersigned to execute and file with the Securities and Exchange Commission ("SEC") and any other authority required by the rules and regulations of the SEC or any market or exchange on which shares of the Company are traded and to submit to the Company, in the place and stead of the undersigned, SEC Forms 3, 4 and 5 and any successor reporting forms required by the SEC in connection with purchases and sales of securities of the Company. This Power of Attorney supersedes and revokes all previous Powers of Attorney executed for the undersigned with respect to the filings of SEC Forms 3, 4 and 5 regarding the purchases and sales of securities of the Company and shall be effective until revoked by a written instrument executed by the undersigned and delivered to the Company at its headquarters to the attention of the General Counsel.

Dated:
December 4, 2012

By:
/s/ Daniel M. Mulvena
Name:
Daniel M. Mulvena

Title:
Director
Thoratec Corporation